Q-TWiST analysis comparing ipilimumab/dacarbazine vs placebo/dacarbazine for patients with stage III/IV melanoma

BACKGROUND: Study CA184024 was a multinational, randomised, double-blind, phase 3 study comparing ipilimumab/dacarbazine (DTIC) vs placebo/DTIC in patients with untreated stage III/IV melanoma, which showed that ipilimumab significantly improves survival in patients with metastatic melanoma. The obj...

Descripción completa

Detalles Bibliográficos
Autores principales: Sherrill, B, Wang, J, Kotapati, S, Chin, K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3708560/
https://www.ncbi.nlm.nih.gov/pubmed/23787916
http://dx.doi.org/10.1038/bjc.2013.298

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3708560/
https://www.ncbi.nlm.nih.gov/pubmed/23787916
http://dx.doi.org/10.1038/bjc.2013.298

Ejemplares similares